Cite
HARVARD Citation
Rothschild, S. et al. (2021). SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non–Small-Cell Lung Cancer—A Multicenter Single-Arm Phase II Trial. Journal of clinical oncology. 39 (26), pp. 2872-2880. [Online].